Combipet ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  3.7% 3.7% 3.7% 3.7% 3.7%  
Bankruptcy risk  5.5% 4.0% 3.5% 3.5% 3.2%  
Credit score (0-100)  42 49 52 53 55  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  407 696 1,005 1,094 1,064  
EBITDA  90.8 336 645 681 548  
EBIT  90.8 336 645 681 548  
Pre-tax profit (PTP)  81.7 329.2 641.1 671.8 521.6  
Net earnings  62.2 256.1 496.8 520.9 402.7  
Pre-tax profit without non-rec. items  81.7 329 641 672 522  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  335 592 1,088 1,159 1,262  
Interest-bearing liabilities  154 135 124 500 689  
Balance sheet total (assets)  714 1,193 1,685 2,398 2,566  

Net Debt  111 -9.3 -30.4 236 158  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  407 696 1,005 1,094 1,064  
Gross profit growth  -13.7% 70.8% 44.5% 8.9% -2.7%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  714 1,193 1,685 2,398 2,566  
Balance sheet change%  -7.3% 67.0% 41.2% 42.3% 7.0%  
Added value  90.8 336.4 645.2 681.4 548.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  22.3% 48.4% 64.2% 62.3% 51.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  12.2% 35.3% 45.3% 33.4% 21.7%  
ROI %  19.7% 55.3% 67.2% 47.5% 29.8%  
ROE %  20.4% 55.3% 59.1% 46.4% 33.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  47.0% 49.6% 64.6% 48.3% 49.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  122.5% -2.8% -4.7% 34.6% 28.9%  
Gearing %  46.0% 22.7% 11.4% 43.1% 54.6%  
Net interest  0 0 0 0 0  
Financing costs %  5.8% 5.0% 8.2% 3.1% 3.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.2 1.4 2.0 0.9 1.2  
Current Ratio  1.9 2.0 2.8 1.9 2.0  
Cash and cash equivalent  43.1 143.8 154.6 263.8 530.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  335.4 591.5 1,088.3 1,159.2 1,265.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  91 336 645 681 548  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  91 336 645 681 548  
EBIT / employee  91 336 645 681 548  
Net earnings / employee  62 256 497 521 403